Bivalirudin versus heparin in patients with or without bail-out GPI use: a pre-specified subgroup analysis from the BRIGHT-4 trial.

Autor: Liao, Jia1,2 (AUTHOR), Qiu, Miaohan1 (AUTHOR), Feng, Xiaojian3 (AUTHOR), Chen, Kui4 (AUTHOR), Zhang, Dingbao5 (AUTHOR), Zou, Yuncheng6 (AUTHOR), Zheng, Xiaohui7 (AUTHOR), Zhao, Gang8 (AUTHOR), Tian, Nailiang9 (AUTHOR), Zheng, Zeqi10 (AUTHOR), Peng, Xiaoping10 (AUTHOR), Yang, Qing11 (AUTHOR), Liang, Zhenyang1 (AUTHOR), Li, Yi1 (AUTHOR) doctorliyi@126.com, Han, Yaling1 (AUTHOR) hanyaling@163.net, Stone, Gregg W.12 (AUTHOR)
Zdroj: BMC Medicine. 9/27/2024, Vol. 22 Issue 1, p1-12. 12p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje